NEW YORK (GenomeWeb News) – Illumina reported after the close of the market Monday that its fourth-quarter revenues climbed 24 percent, topping analysts' consensus estimate.

The San Diego-based genetic analysis products firm brought in total revenues of $309.3 million for the three months ended Dec. 30, 2012, in line with its pre-announcement and up from $250.1 million for the fourth quarter of 2011. It beat the consensus Wall Street estimate of $305.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.